This decrease reaches statistical significance, when compared to the HG, for IFNγ+IL-17+ CD4 T cells from CCA patients at T0, and for IL-17+ CD8 T cells in CCA patients, both at T0 and T1 (Table 5). The gene discussed is CD4; the disease is cholangiocarcinoma.